GSTO polymorphism analysis in thyroid nodules suggest that GSTO1 variants do not influence the risk for malignancy

European Journal of Cancer Prevention

Volumn 14, Issue 3, 2005, Pages 277-280

  Granja, F ^a   Morari, E C ^a   Assumpcao L V M ^a   Ward, L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cancer; GSTO1; Susceptibility

Indexed keywords

ALANINE; ARSENIC; ASPARTIC ACID; CARCINOGEN; DRINKING WATER; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE OMEGA; GLUTATHIONE TRANSFERASE OMEGA 1; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BENIGN TUMOR; BIOTRANSFORMATION; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GSTO1 GENE; HUMAN; INCIDENCE; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NODULAR GOITER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; THYROID ADENOMA; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RISK FACTORS; THYROID NEOPLASMS; THYROID NODULE;

EID: 20344401561     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200506000-00013     Document Type: Article

References (20)

1. Board PG, Coggan M, Chelvanayagam G, et al. (2000). Identification, characterization and crystal structure of the omega class of glutathione transferases. J Biol Chem 275: 24798-24806.
2. Cerda-Flores RM, Budowle B, Jin L, et al. (2002). Maximum likelihood estimates of admixture in Northeastern Mexico using 13 short tandem repeat loci. Am J Human Biol 14: 429-439.
3. Dulhunty A, Gage P, Curtis S, Chelvanayagam G, Board P (2001). The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J Biol Chem 276: 3319-3323.
4. Friedman GD, Ury HK (1983). Screening for possible drug cardnogenicity: second report of findings. J Natl Cancer Inst 71:1165-1175.
5. Granja F, Morari J, Morari EC, et al. (2004). GST profiling may be useful in the screening for thyroid nodule malignancy. Cancer Letts 209: 129-137.
6. Haselkorn T, Stewart SL, Horn-Ross PL (2003). Why are thyroid cancer rates so high in Southeast Asian women living in the United States? The Bay Area thyroid cancer study. Cancer Epidemiol Biomark Prev 12: 144-150.
7. Hayes JD, Strange RC (1995). Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 22: 193-207.
8. Hirakawa M, Tanaka T, Hashimoto Y, et al. (2002). JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res 30: 158-162.
9. Mack WJ, Preston-Martin S, Bernstein L, Qian D (2002). Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol 12: 395-401.
10. Mannervik B (1985). The isozymes of glutathione S-transferase. Adv Enzymol 57: 357-417.
11. McClain RM (1992). Thyroid gland neoplasia: non-genotoxic mechanisms. Toxicol Lett 64-65: 397-408.
12. Memon A, Varghese A, Suresh A (2002). Benign thyroid disease and dietary factors in thyroid cancer: a case-control study in Kuwait. Br J Cancer 86: 1745-1750.
13. Morari EC, Leite JLP, Granja F, Assumpção LVM, Ward LS (2002). The null genotype of glutathione S-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol Biomarkers Prev 11: 1485-1488.
14. Ron E, Kleinerman RA, Boice Jr JD, et al. (1987). A population-based case-control study of thyroid cancer. J Natl Cancer Inst 79: 1-12.
15. Schlumberger MJ (2000). Papillary and follicular thyroid carcinoma. Baillière's Best Pract Res Clin Endo Metab 14: 601-613.
16. Strange RC, Fryer AA (1999). The glutathione S-transferases: influence of polymorphism on cancer susceptibility. In: Vineis P, Malatus N, Lang M (editors): et al. Metabolic Polymorphisms and Susceptibility to Cancer. Lyon: IARC Scientific Publication No. 148. IARC; pp. 231-249.
17. Tanaka-Kagawa T, Jinno H, Hasegawa T, et al. (2003). Functional characterization of two variant human GSTO1-1s (Ala140Asp and Thr217Asn). Biochem Biophys Res Commun 301: 516-520.
18. Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG (2003). Characterization of the human omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 13: 131-144.
19. Yin ZL, Dahlstrom JE, Le Couleur DG, Board PG (2001). Immunohistochemistry of omega class glutathione S-transferase in human tissues. J Histochem Cytochem 49: 983-987
20. Yu RC, Hsu KH, Chen CJ, Froines JR (2000). Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev 9: 1259-1262.